Melanie Lee
Directeur/Bestuurslid bij UK DRI Ltd.
Profiel
Melanie Georgina Lee founded NightstaRx Ltd.
in 2014, where she worked as Chief Executive Officer.
Dr. Lee also founded Think10, where she worked as Director.
Dr. Lee also currently works at BIAL-Portela & Cia SA, as Non-Executive Director from 2023, Lee & Smith Properties Ltd., as Director, and UK DRI Ltd., as Trustee from 2017.
Dr. Lee also formerly worked at Lifearc, as Chief Executive Officer & Trustee from 2018 to 2023, Cancer Research Technology Ltd., as Chairman from 2004 to 2007, Cancer Research UK, as Deputy Chairman from 2003 to 2011, H.
Lundbeck A, as Independent Non-Executive Director in 2015, Sanofi, as Independent Director from 2017 to 2022, BTG Ltd., as Independent Non-Executive Director from 2012 to 2014, Celltech Group Ltd., as Director-Research & Development from 1998 to 2009, Ipsen Bioinnovation Ltd., as Director from 2009 to 2013, BTG Ltd., as Chief Scientific Officer from 2014 to 2018, GlaxoWellcome, as Research Unit Head-Receptor Systems from 1988 to 1998, UCB Pharma, Inc., as Executive Vice President-Research & Development, GlaxoSmithKline Pharmaceuticals SA (Belgium), as Principal, and UCB Celltech, as President-New Medicines from 1998 to 2009.
Dr. Lee received her undergraduate degree from York University and doctorate degree from The National Institute For Medical Research.
Actieve functies van Melanie Lee
| Bedrijven | Functie | Begin |
|---|---|---|
UK DRI Ltd.
 UK DRI Ltd. BiotechnologyHealth Technology UK DRI Ltd. is a national institute that specializes in biomedical, care, and translational dementia research. The joint venture company is based in London, UK. The British company breaks new ground by bringing together world-leading expertise in these fields. | Directeur/Bestuurslid | 20-12-2017 |
| Lee & Smith Properties Ltd. | Directeur/Bestuurslid | - |
BIAL-Portela & Cia SA
 BIAL-Portela & Cia SA Pharmaceuticals: MajorHealth Technology BIAL-Portela & Cia SA manufactures pharmaceutical products. It develops drugs in therapeutic areas such as antibiotics, anti-inflammatory, anti-ulcer, anti-depressants, anti-asthmatic, and analgesics. The firm also offers anti-allergic vaccines and the means of diagnosing allergies. It has two production plants and two R&D centers in the Porto area and in Bilbao, Spain. The company was founded by António Portela in 1924 and is headquartered in Coronado, Portugal. | Directeur/Bestuurslid | 23-05-2023 |
Eerdere bekende functies van Melanie Lee
| Bedrijven | Functie | Einde |
|---|---|---|
Lifearc
 Lifearc Miscellaneous Commercial ServicesCommercial Services Lifearc provides research services. It specializes in intellectual property management, drug discovery, medical diagnostics and antibody engineering. The firm services include complete technology transfer service for scientists in MRC units and institutes, Awards to Inventors, Collaborative drug discovery and antibody engineering, Funding early stage research with commercial/translational potential and protecting new ideas. The company is headquartered in London, the United Kingdom. | Algemeen Directeur | 30-09-2023 |
| SANOFI | Directeur/Bestuurslid | 03-05-2022 |
| BTG | Hoofd Techniek/Wetenschap/O&O | 01-01-2018 |
| H. LUNDBECK A/S | Directeur/Bestuurslid | 25-03-2015 |
| BTG | Directeur/Bestuurslid | 25-09-2014 |
Opleiding van Melanie Lee
| York University | Undergraduate Degree |
| The National Institute For Medical Research | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| H. LUNDBECK A/S | Health Technology |
| SANOFI | Health Technology |
| Bedrijven in privébezit | 15 |
|---|---|
Cancer Research Technology Ltd.
 Cancer Research Technology Ltd. Medical SpecialtiesHealth Technology Cancer Research Technology Ltd. develops cancer therapeutics, vaccines, and diagnostics. The firm also provides project development, commercialization, drug discovery, clinical development, imaging, and funding services. The company was founded in 2002 and is headquartered in London, the United Kingdom. | Health Technology |
NightstaRx Ltd.
 NightstaRx Ltd. Medical/Nursing ServicesHealth Services NightstaRx Ltd. develops and commercializes therapies for retinal dystrophies. It offers retinal gene therapy that provides one-time cure for choroideremia (a rare inherited cause of blindness) and other retinal dystrophies. The company was founded by Robert MacLaren, Miguel Seabra, and Matthew During in January 2014 and is headquartered in London, the United Kingdom. | Health Services |
BTG Ltd.
 BTG Ltd. Pharmaceuticals: MajorHealth Technology BTG Ltd. is a global healthcare company, which focuses on interventional medicine that can help physicians to treat patients through minimally invasive procedures. It operates through the following segments: Product, Licensing, and Other. The firm's products include CroFab, DigiFab, Voraxage. The company was founded on December 12, 1991 and is headquartered in Farnham, the United Kingdom. | Health Technology |
UCB Pharma, Inc.
 UCB Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services UCB Pharma, Inc. provides research, development & commercialisation of pharmeceutical and biotechnology products. Its products are Keppra, Xyzal, Atarax, Lortab, Dipentum, and Tussionex. UCB Pharma develops small and large molecule treatments for a variety of diseases and ailemts. The company was founded by Emmanuel Janssen in 1928 and is headquartered in Smyrna, GA. | Commercial Services |
GlaxoSmithKline Pharmaceuticals SA (Belgium)
 GlaxoSmithKline Pharmaceuticals SA (Belgium) Pharmaceuticals: MajorHealth Technology GlaxoSmithKline Pharmaceuticals SA develops and manufactures pharmaceuticals and vaccines. The company is headquartered in Wavre, Belgium. | Health Technology |
Celltech Group Ltd.
 Celltech Group Ltd. Financial ConglomeratesFinance Part of UCB SA, Celltech Group Ltd. is an investment holding British company. The company is based in Slough, UK. Celltech Group was founded in 1987. | Finance |
| Think10 | |
Cancer Research UK
 Cancer Research UK Miscellaneous Commercial ServicesCommercial Services Cancer Research UK provides cancer research services. It supports and undertakes research on the biology and causes of cancer and develops anti-cancer drugs. The firm also provides general information about cancer and types of treatments and funds projects that help patients cope with the side effects of cancer and its treatment. Its institute also operates an online portal CancerHelp UK that provides patient information. The company was founded in 2001 and is headquartered in London, the United Kingdom. | Commercial Services |
| GlaxoWellcome /Pharmocology Unit/ | Commercial Services |
UCB Celltech
 UCB Celltech BiotechnologyHealth Technology Part of UCB SA, UCB Celltech is a British company that develops novel therapeutic products for humans. The company is based in Slough, UK and was founded in 2006. | Health Technology |
Ipsen Bioinnovation Ltd.
 Ipsen Bioinnovation Ltd. BiotechnologyHealth Technology Ipsen Bioinnovation Ltd. Engages in the research and development of pharmaceutical products. The company was founded in 2005 and is headquartered in Abingdon, the United Kingdom. | Health Technology |
Lifearc
Lifearc Miscellaneous Commercial ServicesCommercial Services Lifearc provides research services. It specializes in intellectual property management, drug discovery, medical diagnostics and antibody engineering. The firm services include complete technology transfer service for scientists in MRC units and institutes, Awards to Inventors, Collaborative drug discovery and antibody engineering, Funding early stage research with commercial/translational potential and protecting new ideas. The company is headquartered in London, the United Kingdom. | Commercial Services |
UK DRI Ltd.
UK DRI Ltd. BiotechnologyHealth Technology UK DRI Ltd. is a national institute that specializes in biomedical, care, and translational dementia research. The joint venture company is based in London, UK. The British company breaks new ground by bringing together world-leading expertise in these fields. | Health Technology |
| Lee & Smith Properties Ltd. | |
BIAL-Portela & Cia SA
BIAL-Portela & Cia SA Pharmaceuticals: MajorHealth Technology BIAL-Portela & Cia SA manufactures pharmaceutical products. It develops drugs in therapeutic areas such as antibiotics, anti-inflammatory, anti-ulcer, anti-depressants, anti-asthmatic, and analgesics. The firm also offers anti-allergic vaccines and the means of diagnosing allergies. It has two production plants and two R&D centers in the Porto area and in Bilbao, Spain. The company was founded by António Portela in 1924 and is headquartered in Coronado, Portugal. | Health Technology |
